相关实验视频

Updated: Jun 17, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

SARS-CoV-2 Mpro的共价小分子抑制剂:关于它们的设计,分类,生物活性和结合相互作用的见解

Ahmed M Shawky¹, Faisal A Almalki², Hayat Ali Alzahrani³

¹Science and Technology Unit (STU), Umm Al-Qura University, Makkah, 21955, Saudi Arabia.

European journal of medicinal chemistry

|August 9, 2024

概括

研究人员正在开发针对SARS-CoV-2主要蛋白酶 (Mpro) 的共价抑制剂,用于COVID-19治疗. 本次审查强调了它们的设计,活性和对抗新出现的病毒突变的潜力.

科学领域:

药用化学医学化学
病毒学病毒学
药物发现药物发现药物发现

背景情况:

随着COVID-19的流行,人们开始对SARS-CoV-2的治疗方法进行广泛的研究.
病毒主要蛋白酶 (Mpro) 是抑制病毒复制的关键标.
小分子共价抑制剂已经显示出对Mpro.

研究的目的:

审查共价SARS-CoV-2 Mpro抑制剂的设计,化学和分类.
讨论生物活性,包括Mpro抑制和抗病毒作用.
探索这些抑制剂与Mpro.com的潜在机制和相互作用.

主要方法:

关于对SARS-CoV-2的共价Mpro抑制剂的文献综述.
分析Mpro-抑制剂复合物的晶体结构.
讨论结构-活动关系 (SAR) 研究和约束模式.

主要成果:

确定了针对SARS-CoV-2 Mpro的多种共价抑制剂,其IC50值从微分子到纳米分子不等.
许多抑制剂对来自其他冠状病毒 (SARS-CoV-1,MERS-CoV) 的Mpro表现出广泛的活性.
双抑制Mpro和PLpro可以提供增强的治疗效益.

结论:

性Mpro抑制剂是强大的抗病毒药物,尽管Mpro突变需要开发下一代药物.
了解抑制剂-Mpro相互作用对于设计有效的治疗方法至关重要.
本综述为开发针对SARS-CoV-2和未来冠状病毒威胁的新型,强效Mpro抑制剂提供了见解.

关键词:

活动活动活动.结合性相互作用是有约束性的.分类分类分类分类.协同抑制剂协同抑制剂设计设计设计设计设计设计.在SARS-COV-2 Mpro中使用.

更多相关视频

Engineering Antiviral Agents via Surface Plasmon Resonance

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Conjugated Proteins

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...